Neko Health, co-founded by Daniel Ek, will open its inaugural American office in SoHo, Manhattan on September 24, marking the company’s first physical presence in the U.S. after significant traction in Europe.
- Opening first U.S. office in Manhattan on September 24
- Uses body scans, bloodwork, and fitness data for health insights
- Has scanned 100,000 people, 25,000 on U.S. waitlist
What happened
Neko Health, a health technology startup founded by Spotify co-founder Daniel Ek and CEO Hjalmar Nilsonne, is set to open its first U.S. office in SoHo, Manhattan at 300 Lafayette Street on September 24. The company has previously established operations in the U.K. and Sweden and uses a combination of body-scanning technology, bloodwork, and data from fitness devices to deliver comprehensive health assessments.
The startup has already completed over 100,000 body scans globally and has generated significant interest in the U.S., with more than 25,000 New Yorkers currently on a waitlist to access the service. This marks a major step in their international expansion strategy and entry into the large and competitive American health technology market.
Why it matters
Neko Health’s expansion highlights growing consumer demand for innovative, tech-driven health diagnostics that go beyond traditional testing methods. By merging body-scanning capabilities with blood tests and wearable fitness data, Neko offers a holistic health evaluation that can help individuals better understand their wellness and potentially detect early signs of disease.
This move also places Neko alongside a rising wave of health startups pioneered by tech founders or backed by venture capital that focus on personalized and preventive health services. The U.S. market is particularly strategic given its size, high healthcare spending, and consumer openness to new wellness technologies, which could accelerate Neko’s growth trajectory.
What to watch next
Key indicators to monitor will include how quickly Neko converts its waitlist into app users in New York and whether it can establish partnerships with local health providers or wellness communities to broaden its footprint. Additionally, competition from other emerging body-scanning and health-assessment startups—some integrating AI and novel spa experiences—will test Neko’s differentiation in the space.
Funding and product enhancements will also be crucial as Neko scales. Having recently secured a $700 million Series C, the startup is well capitalized, but ongoing innovation and market adoption in the U.S. will determine its long-term leadership in this rapidly evolving segment of digital health.